The global Medical Waste Management Market was valued at USD 11.43 billion in 2023 and is projected to grow from USD 12.04 billion in 2024 to USD 18.20 billion by 2031, registering a compound annual growth rate (CAGR) of 6.08% during the forecast period, according to a report by Kings Research. The market covers the systematic handling, treatment and disposal of waste generated by hospitals, diagnostic laboratories, research centers and pharmaceutical facilities, including infectious waste, pathological waste, sharps and chemical residues.
Market Overview
Medical waste management begins with categorization and segregation at the source, followed by collection, storage, treatment and safe final disposal. Treatment methods include incineration, autoclaving and chemical disinfection. These processes are essential for protecting public health and the environment from biohazardous materials, and they help healthcare providers comply with an expanding body of regulatory standards.
The integration of sustainability and circular economy principles is one of the strongest forces supporting market growth. Governments, healthcare institutions and environmental agencies are encouraging eco-friendly alternatives, such as energy recovery from waste, recycling of non-hazardous components, and the use of biodegradable materials in healthcare packaging and consumables. Service providers are aligning their strategies with these principles to reduce landfill dependence and lower carbon emissions. Automated waste segregation systems and energy-efficient treatment technologies are also gaining traction as circular models take hold across healthcare systems.
Key Highlights from the Report
- The market was valued at USD 11.43 billion in 2023 and is expected to expand at a 6.08% CAGR from 2024 to 2031.
- North America held a 36.73% share in 2023, valued at USD 4.20 billion.
- The hazardous waste segment generated USD 6.67 billion in revenue in 2023.
- The offsite treatment segment is expected to reach USD 10.41 billion by 2031.
- Incineration secured the largest treatment share, at 39.55% in 2023.
- Asia Pacific is anticipated to grow at a CAGR of 6.48% over the forecast period.
Market Driver: Growing Awareness of Environmental and Health Hazards
Heightened awareness of the consequences of improper disposal is encouraging public and private healthcare institutions to adopt safer practices. Exposure to infectious waste, toxic chemicals or sharp instruments can lead to serious health complications and environmental contamination. Growing stakeholder concern is accelerating the adoption of sustainable and efficient waste management systems.
Recycling pilots illustrate the shift. In October 2023, BD and Casella Waste Systems announced successful results from a pilot program to recycle used syringes and needles, which diverted 40,000 pounds of medical waste from landfills. Initiatives of this kind show that safe disposal and resource recovery can be pursued together, opening new service categories for providers.
Market Challenge: Regulatory Compliance and Disposal Restrictions
Strict regulatory requirements surrounding hazardous waste disposal remain a notable challenge. Rules differ by region and often demand high compliance costs and extensive documentation. Key players are responding by investing in technologies that streamline compliance, including automated tracking systems for waste disposal. Many are also partnering with local authorities and regulators to stay ahead of evolving laws, while placing greater emphasis on employee training to reduce risk and improve operational efficiency.
Market Trend: Outsourcing by Healthcare Providers
Healthcare institutions are increasingly outsourcing medical waste handling to specialized third-party providers to improve compliance and reduce operational risk. Outsourcing lets hospitals and clinics concentrate on patient care while licensed professionals manage regulatory requirements and best practices. In October 2024, the University of California entered a systemwide agreement with Clean Harbors to deliver hazardous and medical waste disposal services across all UC campuses, medical centers, laboratories and affiliated facilities. Contracts of this scale are opening new opportunities for waste management companies in every region.
Segmentation Analysis
By type of waste: The hazardous waste segment earned USD 6.67 billion in 2023, supported by the high volume of infectious, pathological and chemically contaminated materials generated by hospitals and laboratories.
By treatment site: Offsite treatment held 58.35% of the market in 2023. Specialized facilities can handle large volumes cost-efficiently, ensure regulatory compliance and relieve providers of on-site operational burden. The segment is expected to reach USD 10.41 billion by 2031.
By treatment: Incineration is projected to reach USD 6.97 billion by 2031. Its ability to treat large volumes of hazardous and infectious waste, reduce waste volume and eliminate pathogens keeps it the leading method, even as alternatives such as autoclaving and chemical treatment evolve.
Regional Analysis
North America accounted for around 36.73% of the global market in 2023, a valuation of USD 4,199.2 million. The shift toward outpatient care and same-day surgeries has increased the number of ambulatory surgical centers and standalone clinics, which generate steady volumes of regulated waste such as sharps, contaminated personal protective equipment and pharmaceuticals. The U.S. and Canada are also centralizing treatment operations in large-scale, high-capacity plants equipped with autoclaves, incinerators and chemical disinfection units, lowering per-unit treatment costs. In October 2024, Stericycle introduced a new hospital, medical and infectious waste incinerator facility at the Tahoe Reno Industrial Center in Nevada. The 110,000-square-foot site represents an investment of roughly USD 110 million.
Asia Pacific is poised to grow at a CAGR of 6.48%. Rapid urbanization is expanding multi-specialty hospitals, diagnostic laboratories and private clinics, all generating rising volumes of biomedical waste. With limited in-house treatment capacity, most institutions rely on specialized vendors. In February 2025, the Government of India introduced the automated biomedical waste treatment plant “Sṛjanam” at AIIMS New Delhi, developed by CSIR-NIIST. The system disinfects infectious waste such as blood, sputum, urine and lab disposables without relying on expensive, energy-heavy incineration.
Regulatory Landscape
In the U.S., medical waste is regulated at the state level, guided by EPA recommendations and the Resource Conservation and Recovery Act for hazardous waste. The UK manages healthcare waste under the Environmental Protection Act 1990 and the Controlled Waste Regulations 2012, with Health Technical Memorandum 07-01 setting best practices. China regulates the full lifecycle of medical waste under the State Council’s Regulations on the Administration of Medical Wastes. India’s Bio-Medical Waste Management Rules, 2016 categorize waste into four groups and require facilities to treat and dispose of biomedical waste within 48 hours.
Competitive Landscape
Market participants are strengthening their positions through collaboration and technological innovation. In January 2024, Northwell Health partnered with cleantech company Envetec to deploy its GENERATIONS 1 technology, designed to treat more than 500,000 pounds of regulated medical waste annually at the source, including single-use laboratory plastics, glass, PPE and sharps containers.
Major companies profiled in the report include Veolia, Clean Harbors, Stericycle, WM Intellectual Property Holdings, Republic Services, Waste Connections, Cleanaway, Casella Waste Systems, Sharps Compliance, Reworld, REMONDIS, BioMedical Waste Solutions, BWS Incorporated, EcoMed Services and Gamma Waste Services.
Recent Developments
- April 2025: Veolia expanded its partnership with MassBio through a multi-year contract extension, covering waste management services and digital energy efficiency management to help members meet Boston and Cambridge carbon reduction mandates.
- March 2025: Reworld completed its acquisition of R.E.D. Technologies, a privately owned provider of profiled waste and field remediation services, to advance resource recovery, recycling and reuse.
- June 2024: Cleanaway acquired Citywide Waste for USD 110 million, securing a 35-year lease on the Dynon Road waste transfer station in West Melbourne, Australia.
Outlook
Looking ahead, the market is expected to benefit from tighter regulation, rising healthcare volumes and continued investment in treatment technologies that cut emissions and landfill use. Providers that combine compliance tracking, on-site and offsite treatment capacity and credible sustainability credentials are likely to be best placed as healthcare systems consolidate their waste contracts. Kings Research notes that emerging markets, where infrastructure and staff training gaps still limit safe disposal, represent a significant long-term opportunity for both technology vendors and service providers.
About Kings Research
Kings Research is a market research and consulting firm that publishes syndicated reports and custom studies across healthcare, chemicals, materials, energy, technology and consumer sectors. Its reports combine quantitative market sizing with analysis of drivers, challenges, trends, regulation and competitive strategy to support business decisions.
Media Contact: Kings Research | 5348 Vegas Dr. Suite 305, Las Vegas, NV 89108 | business@kingsresearch.com
